Paolillo R, Boulanger M, Gâtel P, Gabellier L, De Toledo M, Tempé D, Hallal R, Akl D, Moreaux J, Baik H, Gueret E, Recher C, Sarry J-E, Cartron G, Piechaczyk M, Bossis G. The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias. Haematologica 2022;107(11):2562-2575; https://doi.org/10.3324/haematol.2021.279889.